Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-25-025203

Director acquired 19,084 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Singhvi Rahul Director 2025-10-08 Grant or award +19,084 49,204 D
Loading xslF345X05/ownership.xml…